Literature DB >> 32285331

Sirtuins family as a target in endothelial cell dysfunction: implications for vascular ageing.

Hai-Na Zhang1, Ying Dai1, Chun-Hong Zhang1, Alfred Martin Omondi2, Arunima Ghosh3, Ipsita Khanra4, Manas Chakraborty5, Xu-Ben Yu6,7, Jing Liang8.   

Abstract

The vascular endothelium is a protective barrier between the bloodstream and the vasculature that may be disrupted by different factors such as the presence of diseased states. Diseases like diabetes and obesity pose a great risk toward endothelial cell inflammation and oxidative stress, leading to endothelial cell dysfunction and thereby cardiovascular complications such as atherosclerosis. Sirtuins are NAD+-dependent histone deacetylases that are implicated in the pathophysiology of cardiovascular diseases, and they have been identified to be important regulators of endothelial cell function. A handful of recent studies suggest that disbalance in the regulation of endothelial sirtuins, mainly sirtuin 1 (SIRT1), contributes to endothelial cell dysfunction. Herein, we summarize how SIRT1 and other sirtuins may contribute to endothelial cell function and how presence of diseased conditions may alter their expressions to cause endothelial dysfunction. Moreover, we discuss how the beneficial effects of exercise on the endothelium are dependent on SIRT1. These mainly include regulation of signaling pathways related to endothelial nitric oxide synthase phosphorylation and nitric oxide production, mitochondrial biogenesis and mitochondria-mediated apoptotic pathways, oxidative stress and inflammatory pathways. Sirtuins as modulators of the adverse conditions in the endothelium hold a promising therapeutic potential for health conditions related to endothelial dysfunction and vascular ageing.

Entities:  

Keywords:  Angiogenesis; Exercise; Inflammation; Nitric oxide; Vascular endothelium; miRNA

Year:  2020        PMID: 32285331     DOI: 10.1007/s10522-020-09873-z

Source DB:  PubMed          Journal:  Biogerontology        ISSN: 1389-5729            Impact factor:   4.277


  8 in total

1.  Plasma Exosomal miR-199a-5p Derived from Preeclampsia with Severe Features Impairs Endothelial Cell Function via Targeting SIRT1.

Authors:  Zhirui Chen; Mengying Wu; Haixia Huang; Hui Tao; Li Zou; Qingqing Luo
Journal:  Reprod Sci       Date:  2022-09-07       Impact factor: 2.924

Review 2.  NAD+ and Vascular Dysfunction: From Mechanisms to Therapeutic Opportunities.

Authors:  Mahmoud Abdellatif; Heiko Bugger; Guido Kroemer; Simon Sedej
Journal:  J Lipid Atheroscler       Date:  2022-04-06

Review 3.  The Hyperoxic-Hypoxic Paradox.

Authors:  Amir Hadanny; Shai Efrati
Journal:  Biomolecules       Date:  2020-06-25

Review 4.  Histone Deacetylases (HDACs) and Atherosclerosis: A Mechanistic and Pharmacological Review.

Authors:  Xiaona Chen; Yanhong He; Wenjun Fu; Amirhossein Sahebkar; Yuhui Tan; Suowen Xu; Hong Li
Journal:  Front Cell Dev Biol       Date:  2020-11-12

Review 5.  Targeting the epigenome in in-stent restenosis: from mechanisms to therapy.

Authors:  Xi Yang; Yanyan Yang; Junjie Guo; Yuanyuan Meng; Min Li; Panyu Yang; Xin Liu; Lynn Htet Htet Aung; Tao Yu; Yonghong Li
Journal:  Mol Ther Nucleic Acids       Date:  2021-01-26       Impact factor: 8.886

Review 6.  SIRT1 Antagonizes Oxidative Stress in Diabetic Vascular Complication.

Authors:  Teng Meng; Weifeng Qin; Baohua Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-16       Impact factor: 5.555

7.  Decreased Serum Levels of SIRT1 and SIRT3 Correlate with Severity of Skin and Lung Fibrosis and Peripheral Microvasculopathy in Systemic Sclerosis.

Authors:  Mirko Manetti; Irene Rosa; Bianca Saveria Fioretto; Marco Matucci-Cerinic; Eloisa Romano
Journal:  J Clin Med       Date:  2022-03-01       Impact factor: 4.241

8.  The impact of cardiomotor rehabilitation on endothelial function in elderly patients with chronic heart failure.

Authors:  Juming Chen; Shenhong Gu; Yanling Song; Xinbo Ji; Wangyuan Zeng; Xiaoxi Wang; Yachun Wang; Qingfeng Feng
Journal:  BMC Cardiovasc Disord       Date:  2021-11-01       Impact factor: 2.298

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.